145 related articles for article (PubMed ID: 24739633)
1. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.
Ostvik AE; Granlund Av; Gustafsson BI; Torp SH; Espevik T; Mollnes TE; Damås JK; Sandvik AK
Inflamm Bowel Dis; 2014 Jun; 20(6):995-1003. PubMed ID: 24739633
[TBL] [Abstract][Full Text] [Related]
2. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
Østvik AE; Granlund AV; Torp SH; Flatberg A; Beisvåg V; Waldum HL; Flo TH; Espevik T; Damås JK; Sandvik AK
Clin Exp Immunol; 2013 Sep; 173(3):502-11. PubMed ID: 23668802
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
[TBL] [Abstract][Full Text] [Related]
5. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
8. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
Sugihara T; Kobori A; Imaeda H; Tsujikawa T; Amagase K; Takeuchi K; Fujiyama Y; Andoh A
Clin Exp Immunol; 2010 Jun; 160(3):386-93. PubMed ID: 20089077
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
10. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
11. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
12. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
13. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.
Halstensen TS; Mollnes TE; Garred P; Fausa O; Brandtzaeg P
Gut; 1992 Jul; 33(7):902-8. PubMed ID: 1379568
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
15. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease.
Steenholdt C; Andresen L; Pedersen G; Hansen A; Brynskov J
Scand J Gastroenterol; 2009; 44(2):195-204. PubMed ID: 18985539
[TBL] [Abstract][Full Text] [Related]
17. Crohn's Disease Patients in Remission Display an Enhanced Intestinal IgM⁺ B Cell Count in Concert with a Strong Activation of the Intestinal Complement System.
Preisker S; Brethack AK; Bokemeyer A; Bettenworth D; Sina C; Derer S
Cells; 2019 Jan; 8(1):. PubMed ID: 30669641
[TBL] [Abstract][Full Text] [Related]
18. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA
J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
20. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
